KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Edwards Lifesciences (EW) Shares Repurchased (2016 - 2026)

Edwards Lifesciences has reported Shares Repurchased over the past 17 years, most recently at $40.6 million for Q4 2025.

  • For Q4 2025, Shares Repurchased fell 59.44% year-over-year to $40.6 million; the TTM value through Dec 2025 reached $893.4 million, down 22.94%, while the annual FY2025 figure was $893.4 million, 22.94% down from the prior year.
  • Shares Repurchased for Q4 2025 was $40.6 million at Edwards Lifesciences, down from $588.7 million in the prior quarter.
  • Over five years, Shares Repurchased peaked at $901.0 million in Q3 2024 and troughed at $200000.0 in Q1 2024.
  • A 5-year average of $258.6 million and a median of $166.2 million in 2023 define the central range for Shares Repurchased.
  • Biggest five-year swings in Shares Repurchased: crashed 99.92% in 2024 and later soared 129200.0% in 2025.
  • Year by year, Shares Repurchased stood at $96.5 million in 2021, then surged by 797.41% to $866.0 million in 2022, then tumbled by 48.22% to $448.4 million in 2023, then crashed by 77.68% to $100.1 million in 2024, then crashed by 59.44% to $40.6 million in 2025.
  • Business Quant data shows Shares Repurchased for EW at $40.6 million in Q4 2025, $588.7 million in Q3 2025, and $5.5 million in Q2 2025.